YE4

N-(4-chlorobenzyl)-1-methyl-6-(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

Created:	2021-02-23
Last modified:	2021-04-07

Find Related PDB Entry
1 entries where YE4 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	54
Chiral Atom Count	0
Bond Count	57
Aromatic Bond Count	12

2D diagram of YE4

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-(4-chlorobenzyl)-1-methyl-6-(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
Synonyms	N-[(4-chlorophenyl)methyl]-6-[(2,3-dihydro-4H-1,4-oxazin-4-yl)methyl]-1-methyl-4-oxo-1,4-dihydroquinoline-3-carboxamide
Systematic Name (OpenEye OEToolkits)	~{N}-[(4-chlorophenyl)methyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxidanylidene-quinoline-3-carboxamide
Formula	C₂₃ H₂₄ Cl N₃ O₃
Molecular Weight	425.908
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c4(ccc(CNC(C1=CN(C)c2ccc(cc2C1=O)CN3CCOCC3)=O)cc4)Cl
SMILES	CACTVS	3.385	CN1C=C(C(=O)NCc2ccc(Cl)cc2)C(=O)c3cc(CN4CCOCC4)ccc13
SMILES	OpenEye OEToolkits	2.0.7	CN1C=C(C(=O)c2c1ccc(c2)CN3CCOCC3)C(=O)NCc4ccc(cc4)Cl
Canonical SMILES	CACTVS	3.385	CN1C=C(C(=O)NCc2ccc(Cl)cc2)C(=O)c3cc(CN4CCOCC4)ccc13
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN1C=C(C(=O)c2c1ccc(c2)CN3CCOCC3)C(=O)NCc4ccc(cc4)Cl
InChI	InChI	1.03	InChI=1S/C23H24ClN3O3/c1-26-15-20(23(29)25-13-16-2-5-18(24)6-3-16)22(28)19-12-17(4-7-21(19)26)14-27-8-10-30-11-9-27/h2-7,12,15H,8-11,13-14H2,1H3,(H,25,29)
InChIKey	InChI	1.03	SXLQSQMKOYVAAW-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	492406
ChEMBL	CHEMBL194433

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.